Common Stock, Shares, Outstanding of ELITE PHARMACEUTICALS INC /NV/ from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 1,074,496,442, a 0.58% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,074,496,442 +6,223,334 +0.58% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 1,073,363,108 +5,090,000 +0.48% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 1,068,363,108 +90,000 +0.01% 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 1,068,363,108 +90,000 +0.01% 31 Mar 2025 10-Q 17 Feb 2026 2026 Q3
Q4 2024 1,068,273,108 +50,491,909 +5% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q3
Q3 2024 1,068,273,108 +54,358,027 +5.4% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q2
Q2 2024 1,068,273,108 +54,358,027 +5.4% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 1,068,273,108 +54,358,027 +5.4% 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 1,017,781,199 +3,866,118 +0.38% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 1,013,915,081 0 0% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 1,013,915,081 +2,633,093 +0.26% 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
Q1 2023 1,013,915,081 +2,633,093 +0.26% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 1,013,915,081 +2,633,093 +0.26% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 1,013,915,081 +2,633,093 +0.26% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 1,011,281,988 0 0% 30 Jun 2022 10-Q 15 Aug 2022 2023 Q1
Q1 2022 1,011,281,988 +2,105,236 +0.21% 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 1,011,281,988 +2,105,236 +0.21% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 1,011,281,988 +2,105,236 +0.21% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 1,011,281,988 +170,303,024 +20% 30 Jun 2021 10-Q 16 Aug 2021 2022 Q1
Q1 2021 1,009,176,752 +168,772,385 +20% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 1,009,176,752 +175,323,182 +21% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 1,009,176,752 +176,334,692 +21% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 840,978,964 +12,085,269 +1.5% 30 Jun 2020 10-Q 14 Aug 2020 2021 Q1
Q1 2020 840,404,367 +15,557,808 +1.9% 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 833,853,570 +13,453,431 +1.6% 31 Dec 2019 10-Q 10 Feb 2020 2020 Q3
Q3 2019 832,842,060 +15,979,811 +2% 30 Sep 2019 10-Q 12 Nov 2019 2020 Q2
Q2 2019 828,893,695 +24,343,637 +3% 30 Jun 2019 10-Q 09 Aug 2019 2020 Q1
Q1 2019 824,846,559 +22,319,798 +2.8% 31 Mar 2019 10-K 29 Jun 2020 2020 FY
Q4 2018 820,400,139 +31,698,312 +4% 31 Dec 2018 10-Q 11 Feb 2019 2019 Q3
Q3 2018 816,862,249 +30,915,283 +3.9% 30 Sep 2018 10-Q 09 Nov 2018 2019 Q2
Q2 2018 804,550,058 +23,850,163 +3.1% 30 Jun 2018 10-Q 09 Aug 2018 2019 Q1
Q1 2018 802,526,761 -125,404,687 -14% 31 Mar 2018 10-K 21 Jun 2019 2019 FY
Q4 2017 788,701,827 -122,443,344 -13% 31 Dec 2017 10-Q 09 Feb 2018 2018 Q3
Q3 2017 785,946,966 -107,623,070 -12% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q2
Q2 2017 780,699,895 +49,828,811 +6.8% 30 Jun 2017 10-Q 09 Aug 2017 2018 Q1
Q1 2017 927,931,448 +216,487,096 +30% 31 Mar 2017 10-K 14 Jun 2018 2018 FY
Q4 2016 911,145,171 +223,980,364 +33% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q3
Q3 2016 893,570,036 +212,813,757 +31% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q2
Q2 2016 730,871,084 +71,857,294 +11% 30 Jun 2016 10-Q 09 Aug 2016 2017 Q1
Q1 2016 711,444,352 +80,383,651 +13% 31 Mar 2016 10-K 14 Jun 2017 2017 FY
Q4 2015 687,164,807 +78,301,109 +13% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q3
Q3 2015 680,756,279 +89,104,248 +15% 30 Sep 2015 10-Q 30 Dec 2015 2016 Q2
Q2 2015 659,013,790 +91,041,717 +16% 30 Jun 2015 10-Q 30 Dec 2015 2016 Q1
Q1 2015 631,060,701 +70,918,271 +13% 31 Mar 2015 10-K 15 Jun 2016 2016 FY
Q4 2014 608,863,698 +95,745,898 +19% 31 Dec 2014 10-Q 17 Feb 2015 2015 Q3
Q3 2014 591,652,031 +96,940,768 +20% 30 Sep 2014 10-Q 14 Nov 2014 2015 Q2
Q2 2014 567,972,073 +172,286,201 +44% 30 Jun 2014 10-Q 14 Aug 2014 2015 Q1
Q1 2014 560,142,430 +185,748,471 +50% 31 Mar 2014 10-K 15 Jun 2015 2015 FY
Q4 2013 513,117,800 +162,777,502 +46% 31 Dec 2013 10-Q 14 Feb 2014 2013 Q3
Q3 2013 494,711,263 +145,046,984 +41% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q2
Q2 2013 395,685,872 +49,469,253 +14% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q1
Q1 2013 374,393,959 +42,744,221 +13% 31 Mar 2013 10-K 30 Jun 2014 2014 FY
Q4 2012 350,340,298 +85,509,563 +32% 31 Dec 2012 10-Q 14 Feb 2013 2012 Q3
Q3 2012 349,664,279 +94,885,205 +37% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q2
Q2 2012 346,216,619 +102,853,088 +42% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q1
Q1 2012 331,649,738 +151,104,081 +84% 31 Mar 2012 10-K 21 Jun 2013 2012 FY
Q4 2011 264,830,735 31 Dec 2011 10-Q 14 Feb 2012 2011 Q3
Q3 2011 254,779,074 30 Sep 2011 10-Q 14 Nov 2011 2011 Q2
Q2 2011 243,363,531 30 Jun 2011 10-Q/A 19 Aug 2011 2011 Q1
Q1 2011 180,545,657 31 Mar 2011 10-K 29 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.